SPCMD-REA: Continuous Deep Sedation Until Death

Sponsor
Société Française d'Anesthésie et de Réanimation (Other)
Overall Status
Completed
CT.gov ID
NCT05108792
Collaborator
(none)
585
64
7.1
9.1
1.3

Study Details

Study Description

Brief Summary

This research is a descriptive observational study conducted in multicenter (intensive care and continuing care units) in France. All data collected is part of the patient record. The main objective is to describe the end-of-life sedative practices following a decision to limit or stop therapy in intensive care unit and continuing care unit.

Condition or Disease Intervention/Treatment Phase
  • Other: NO INTERVENTION

Detailed Description

All participating sites will include last 10 consecutive major patients deceased following a decision to limit or stop therapeutics. The study include only data from patients died before

January 1, 2020. In the case report form the following information will be entered:
  • the characteristics of the unit of intensive care or continuing care unit.

  • Patient Characteristics

  • Characteristics of sedative practices

Study Design

Study Type:
Observational
Actual Enrollment :
585 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Continuous Deep Sedation Until Death Following a Decision to Limit or Stop Treatment in Intensive Care and in Continuous Surveillance Units
Actual Study Start Date :
Feb 26, 2021
Actual Primary Completion Date :
Oct 1, 2021
Actual Study Completion Date :
Oct 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Patients deceased following a decision to limit or stop therapeutics

a

Other: NO INTERVENTION
observational study, no intervention performed

Outcome Measures

Primary Outcome Measures

  1. Description of end-of-life sedative practices [after patient death (before january 1st 2020)]

    Information concerning end-of-life sedative practices are recorder in the CRF (treatments used, patient's and unit characteristics...)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients at the time of death (>18years)

  • Died in intensive care or in continuing care unit

  • Patient died before January 1st, 2020.

  • Patients deceased following a decision to limit or stop therapeutics

Exclusion Criteria:
  • Patients who died of brain death or unexpected cardiac arrest at death of unsuccessful cardiopulmonary resuscitation

  • Patient who expressed during his lifetime his opposition to the use of his data for scientific research

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Amiens Amiens France
2 CHU Angers Angers France
3 CH Arras Arras France
4 CHR Metz Thionville Ars-Laquenexy France
5 CH Henri Mondor d'Aurillac Aurillac France
6 CHU Jean Minjoz Besançon France
7 Centre Hospitalier de Chateau Thierry Château-Thierry France
8 Hôpital d'Instruction des Armées Percy Clamart France
9 CHU Clermont-Ferrand - Site de Gabriel Montpied - Neuroréanimation Clermont-Ferrand France
10 CHU Clermont-Ferrand - Site de Gabriel Montpied - Réa médico chir Clermont-Ferrand France
11 Hôpital Beaujon - Réa hépato digestive Clichy France
12 Hôpital Beaujon - Réa neuro chir Clichy France
13 CH de DAX Dax France
14 CHU de Grenoble - Hôpital A Michallon Grenoble France
15 Hôpital privé de Marne la Vallée Jossigny France
16 Groupe Hospitalier LITTORAL ATLANTIQUE La Rochelle France
17 Centre Hospitalier de Laon - Réanimation Polyvalente Laon France
18 CH de Versailles - André Mignot Le Chesnay France
19 Hôpital Bicêtre Le Kremlin-Bicêtre France
20 CHRU de Lille - Réa Neurochirurgicale Lille France
21 CHRU de Lille - service de déchocage et de soins intensifs - Urgence Lille France
22 CHRU de Lille- Hôpital Huriez Lille France
23 CHU la Timone 2 - Pôle GEST - RUSH Marseille France
24 Hôpital Nord Aphm Marseille France
25 CH Mont de Marsan Mont-de-Marsan France
26 CHU de Montpellier - Hopital Gui de Chauliac - Réa médicale Montpellier France
27 CHU de Montpellier - Hopital Gui de Chauliac Montpellier France
28 CHU MONTPELLIER - Hôpital Arnaud de Villeneuve Montpellier France
29 CHU Montpellier - Hôpital Lapeyronie Montpellier France
30 Centre Hospitalier de Montélimar Montélimar France
31 Groupe hospitalier de la région de Mulhouse et Sud-Alsace _ GHRMSA Mulhouse Mulhouse France
32 CHRU de NANCY Nancy France
33 CHU Nantes, Hôtel-Dieu Nantes France
34 Hôpital Pasteur 2 - CHU de Nice Nice France
35 Hôpital Privé Gériatrique Les Sources- Nice Nice France
36 Centre Hospitalier territorial de Nouméa en Nouvelle Calédonie Nouméa France
37 CHU de Nimes Nîmes France
38 Centre Hospitalier d'Orléans Orléans France
39 Centre Hospitalier Sainte-Anne Paris France
40 CHU Bichat Claude Bernard Paris France
41 Fondation Ophtalmologique Adolphe de Rothschild Paris France
42 Hôpital Lariboisière Paris France
43 Hôpital Pitié-Salpêtrière - Réa neuro chir Paris France
44 Hôpital Pitié-Salpêtrière - Réanimation Polyvalente Paris France
45 Hôpital Pitié-Salpêtrière Paris - SSPI Paris France
46 hôpital Saint Antoine - Paris Paris France
47 CHU de Poitiers Poitiers France
48 CHU de Reims Reims France
49 CHU de Rennes - Réanimation chirurgicale Rennes France
50 CHU de Rennes - Réanimation CTCV Rennes France
51 Hôpitaux Drôme Nord - Site de Romans Romans France
52 CHU de Rouen Rouen France
53 CHU Rouen - Réanimation cardiaque chirurgicale Rouen France
54 Centre Hospitalier Privé Saint-Grégoire Saint-Grégoire France
55 CHRU Strasbourg Strasbourg France
56 Hôpital d'Instruction des Armées Sainte Anne Toulon France
57 CHU de Toulouse - Hôpital Pierre-Paul Toulouse France
58 CHU de Toulouse-Rangueil Toulouse France
59 CHU Rangueil - Toulouse - Réanimation de Néphrologie et Transplantation Toulouse France
60 Clinique Pasteur Toulouse France
61 CHRU Tours, Site Trousseau - Réa chir Tours France
62 CHRU Tours, Site Trousseau - URTC-B Tours France
63 Centre Hospitalier Bretagne Atlantique de Vannes Vannes France
64 Gustave Roussy Villejuif France

Sponsors and Collaborators

  • Société Française d'Anesthésie et de Réanimation

Investigators

  • Study Chair: Matthieu LE DORZE, MD, GH Lariboisière-St Louis

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Société Française d'Anesthésie et de Réanimation
ClinicalTrials.gov Identifier:
NCT05108792
Other Study ID Numbers:
  • SPCMD-REA / NR 2020-01
First Posted:
Nov 5, 2021
Last Update Posted:
Nov 5, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Société Française d'Anesthésie et de Réanimation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2021